Volume : 11, Issue : 03, March – 2024
Title:
FORMULATION AND EVALUATION OF SUBLINGUAL TABLETS OF POORLY AQUEOUS-SOLUBLE DRUG TICAGRELOR USING SUPERDISINTEGRANTS
Authors :
Rafia Fatima, N. Swati, Niranjan Panda*, Amita Sahu, Sudhansu Sekhar Swain
Abstract :
Ticagrelor is an oral antiplatelet drug that is used to decrease the risk of myocardial infarction and stroke in patients with acute coronary syndromes. Sublingual tablets, which disintegrate in the oral cavity beneath the tongue in less than a minute, are solid dosage forms that have the benefit of avoiding first-pass metabolism. The need for sublingual has increased over the past ten years, particularly among the elderly and kids who have swallowing issues. To achieve rapid disintegration in gastric pH and quick action as an oral antiplatelet agent, the current study’s goal was to create sublingual tablets of Ticagrelor using various concentrations of Crosscarmellose Sodium, Sodium starch glycolate, and Cross povidone as superdisintegrants. There are twelve different sublingual tablet formulations were created using wet granulation technology. There is no interaction between the medications and the numerous excipients employed in the formulation, according to FTIR technology studies on the compatibility of drugs and excipients. When compared to the pharmacopeia, the outcomes of the various precompression and postcompression characterizations of tablets were satisfactory. Using a USP II paddle-type dissolution equipment, in vitro release experiments for several formulations were carried out. Formulation TSF12, which contains 2% Crosscarmellose Sodium and 2% Cross povidone, demonstrated complete drug release in less than 30 minutes (>99%), establishing itself as an optimized formulation. Using both superdisintegrants in tandem also demonstrated an improved drug release profile. The zero-order kinetic model was the best formulation. Accelerated stability studies for improved formulation were done to confirm the stability of dosage forms.
Keywords: Ticagrelor, Sublingual tablet, Croscarmellose Sodium, Sodium starch glycolate, Cross povidone, antiplatelet drug.
Cite This Article:
Please cite this article in press Niranjan Panda et al, Formulation And Evaluation Of Sublingual Tablets Of Poorly Aqueous-Soluble Drug Ticagrelor Using Superdisintegrants.,Indo Am. J. P. Sci, 2024; 11 (3).
Number of Downloads : 10
References:
1. Shirwaikar R., Shirwaikar A., Prabu L., Mahalaxmi R., Rajendran K., Kumar C. Studies of superdisintegrant properties of seed mucilage of Ocimum gratissimum. Indian Journal of Pharmaceutical sciences. 2007; 69(6): 753-758.
2. Palkhede M., Amrutkar S., Erande K. Formulation, optimization and evaluation of fast disintegrating tablet of mebeverine HCl. Int J Pharm Pharm Sci. 2012; 4(4):121-125.
3. Pusapati RT, Kumar MK, Rapeti SS, Murthy T. Development of co-processed excipients in the design and evaluation of Ticagrelor calcium tablets by direct compression method. Int J Pharma Investig 2014; 4:102-6.
4. Biradar SS, Bhagavati ST, Kuppasad IJ. FTSF dissolving drug delivery systems: A brief overview. International Journal of Pharmaceutical Sciences, 2006; 4(2).
5. Wael Ali, Alia A. Badawi, Mahmoud A. Mahdy, Hanan M. El-Nahas, Formulation and evaluation of carbamazepine 200mg immediate-release tablets using polyethylene glycol 6000, Int J Pharm Pharm Sci, 2013, 5 (l):114-119.
6. Prajapati ST, Patel MV, Patel CN. Preparation and evaluation of sublingual tablets of Ticagrelor. Int J Pharma Investig 2014; 4:27-31.
7. Narang N, Sharma J. Sublingual mucosa as a route for systemic drug delivery. Int J Pharm Pharm Sci 2011; 3:18-22.
8. Kurosaki Y, Takatori T, Nishimura H, Nakayama T, Kimura T. Regional variation in oral mucosal drug absorption: Permeability and degree of keratinization in hamster oral cavity. Pharm Res 1991; 8:1297-301
9. Czeisler JL, Perlman KP. Diluents. In: Swarbrick TJ, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. New York, NY: Marcel Dekker Inc.; 1991. p. 37-83.
10. Md Sarfaraz, V.G. Joshi, Immediate release solid oral dosage form of salbutamol sulfate: design, optimization and evaluation, Int J Pharm Pharm Sci, 2013, 5 (4): 610-618.
11. Siddiqui MN, Garg G., Sharma PK. FTSF Dissolving Tablets: Preparation, Characterization, and Evaluation: An Overview, International Journal of Current Pharmaceutical Research, 2008, 15(4).
12. Niranjan Panda, Afshan Sultana, A Venkateswar Reddy, G. V. Subba Reddy, M.S.Ansari: Formulation Design and Study the effect of Polyplasdone-XL and AC-Di-Sol on Release Profile of Doxofylline Immediate Release Tablets. Int. J. Pharm. Sci. Rev. Res., 32(2), 2015: 67-76.
13. Balusu H, Reddy P. Formulation and evaluation of fast disintegrating Ticagrelor sublingual tablets. Curr Trends Biotechnol Pharm 2012; 6:84-98.
14. Mahmoud AA, Salah S. FTSF relief from migraine attacks using fTSF-disintegrating sublingual Ticagrelor tablets. Drug Dev Ind Pharm 2012; 38:762-9.
15. Roden DM, Antiarrhythmic Drugs, In: Goodman and Gilman’s Pharmacology Basis of Therapeutics, 10th ed., McGraw Hill Publishing Division, New York 2006, 949-50.
16. Koteswari P, Sunium S, Srinivasababu P, Babu GK, Nithya PD. Formulation Development and evaluation of fast disintegrating tablets of Lamotrigine using the liqui-solid technique. Int J Pharma Investig 2014; 4:207-14.
17. Naik PS., Kurup NS. Design and optimization of fast-dissolving tablets containing metoprolol by sublimation method. IRJP.2010;1(1): 346-357.
18. Leon Lachmann, Herbert A, Liberman, Joseph L. Kaing, The theory and practice of Industrial Pharmacy:293-303.
19. Aulton`s Pharmaceutics, The design & manufacture of medicines, Biopharmaceutics and pharmacokinetics, A Treatise, second edition, Valabh Prakashan, 315-84.
20. S. Agarwal, P. V. K Kumari, Y.S Rao, formulation, evaluation and comparison of dissolution profiles of Eslicarbazepine acetate immediate release tablets using natural binders against synthetic binder, International Journal of Pharmacy and Pharmaceutical Sciences, 2013, 5 (4):192-194.
21. Dalia Abd Elaty Mostafa. Formulation and evaluation of Chlorophenoxamine hydrochloride rapidly disintegrating tablets, Int, Res, J. Pharma. 2014; 5(10): 765-769.
22. M. Akbar, N. Panda, AV Reddy, “Formulation and Evaluation of Doxofylline Sublingual Tablets Using Sodium Starch Glycolate and Crosscarmellose Sodium as Superdisintegrant” Int. J. of Pharm. Res. & All. Sci. 2015; 4(2):90-100.
23. Mohd Shoukhatullah Ansari, Niranjan Panda, Pawan Kumar, Prabhat Kumar; Designing buccal mucoadhesive tablets of Doxofylline by using Ethocel, Carbopol 934P, and Methocel K15M: A method to improve its bioavailability; Int. J. Pharm & Ind. Res., Vol.–10 (02) 2020 [61-76]
24. Sudhir. Maddela, Eswar Gupta. Maddi and Ramarao. Nadendla, Immediate Release Formulation of Valsartan Capsule and Evaluation of its Compatibility by Nonthermal Methods, American Journal of Advanced Drug Delivery, 1 (3), 2013, 180-196.
25. Patel DM, Patel SP, Patel CN. Formulation and evaluation of fast-dissolving tablet containing Domperidone ternary solid dispersion. Int J Pharma Investig 2014; 4:174-82.
26. Subedi RK, Ryoo JP, Moon C, Choi HK. Influence of formulation variables in transdermal drug delivery system containing Ticagrelor. Int J Pharm 2011; 419:209-14.
27. Bhardwaj V, Shukla V, Goyal N, Salim MD, Sharma PK. Formulation and evaluation of fast disintegrating sublingual tablets of amlodipine besylate using different superdisintegrants. Int J Pharm Sci 2010; 2:89-2.
28. Mohd Shoukhatullah Ansari, Afshan Sultana, Niranjan Panda, Sumayya Ather Siddiqui, Aroosa Nahid, and Sana, Formulation and In Vitro, Evaluation of Atorvastatin Orodispersible Tablets Using Sodium Starch Glycolate and Cross Povidone as Superdisintegrant. European Journal of Biomedical and Pharmaceutical Sciences, 2022, Volume 9, Issue 10, 322-331.